Nanomedicine: An Emerging Novel Therapeutic Strategy for Hemorrhagic Stroke

32Citations
Citations of this article
117Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hemorrhagic stroke is one of the most devastating diseases worldwide due to a high rate of disability and mortality with few effective treatments. Recent advances in nanomedicines to promote hemostasis, drug delivery, neuroprotection, and nerve regeneration may provide insight into hemorrhagic stroke treatment. In this review, we first view the pathophysiology and conventional therapeutics of hemorrhagic stroke. Second, we comprehensively summarize the current nanomedicines applied in hemorrhagic stroke, including inorganic nanomaterials, polymer-based nanomaterials, lipid-based nanomaterials, self-assembling peptide-based hydrogel, exosomes, and gel systems. Finally, the challenges, opportunities, and future perspectives of nanomedicines for hemorrhagic stroke are discussed. Thus, this review promotes greater exploration of effective therapies for hemorrhagic stroke with nanomedicines.

Cite

CITATION STYLE

APA

Xu, Y., Chen, A., Wu, J., Wan, Y., You, M., Gu, X., … Hu, B. (2022). Nanomedicine: An Emerging Novel Therapeutic Strategy for Hemorrhagic Stroke. International Journal of Nanomedicine. Dove Medical Press Ltd. https://doi.org/10.2147/IJN.S357598

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free